Sequence information
Variant position: 41 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 514 The length of the canonical sequence.
Location on the sequence:
SLPEEDVAEIQHAEEFLIKP
E SKVAKLDTSQWPLLLKNFDK
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human SLPEEDVAEIQHAEEFLIKPE SKVAKLDTSQWPLLLKNFDK
Mouse PLQEDDVAEIQHAEEFLIKPE SKVAQLDTSQWPLLLKNFDK
Rat PLPEADVAEIQHAEDFLIKPE SKAAQLDTSQWPLLLKNFDR
Chicken SLPDEDVADIQHTEEFLIKPE SRVAQLDTSQWPLLLKNFDK
Caenorhabditis elegans KLEGDDLAEAQQKGSFQLPSS NETAKLDASQWPLLLKNYDK
Drosophila PLDGDDIGTLQKQGNFQIKPS SKIAELDTSQWPLLLKNFDK
Slime mold KSSEKSTQEVEQ----VIKPE -KTPILDTSKWPLLLKNYDQ
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 514
H/ACA ribonucleoprotein complex subunit DKC1
Modified residue
21 – 21
Phosphoserine
Cross
39 – 39
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
Cross
43 – 43
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
Literature citations
X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.
Knight S.W.; Heiss N.S.; Vulliamy T.J.; Greschner S.; Stavrides G.; Pai G.S.; Lestringant G.; Varma N.; Mason P.J.; Dokal I.; Poustka A.;
Am. J. Hum. Genet. 65:50-58(1999)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANTS DKCX VAL-2; GLU-39; LYS-41; THR-65; ALA-66; VAL-321; ILE-350; THR-350; VAL-353 AND ARG-402;
Uncovering global SUMOylation signaling networks in a site-specific manner.
Hendriks I.A.; D'Souza R.C.; Yang B.; Verlaan-de Vries M.; Mann M.; Vertegaal A.C.;
Nat. Struct. Mol. Biol. 21:927-936(2014)
Cited for: SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-413; IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];
Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.
Impens F.; Radoshevich L.; Cossart P.; Ribet D.;
Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014)
Cited for: SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-413; IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];
SUMO-2 orchestrates chromatin modifiers in response to DNA damage.
Hendriks I.A.; Treffers L.W.; Verlaan-de Vries M.; Olsen J.V.; Vertegaal A.C.;
Cell Rep. 10:1778-1791(2015)
Cited for: SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-413; IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];
System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.
Xiao Z.; Chang J.G.; Hendriks I.A.; Sigurdsson J.O.; Olsen J.V.; Vertegaal A.C.;
Mol. Cell. Proteomics 14:1419-1434(2015)
Cited for: SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-413; IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];
Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.
Hendriks I.A.; Lyon D.; Young C.; Jensen L.J.; Vertegaal A.C.; Nielsen M.L.;
Nat. Struct. Mol. Biol. 24:325-336(2017)
Cited for: SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-20; LYS-39; LYS-43; LYS-191; LYS-394; LYS-413; LYS-424; LYS-433 AND LYS-467; IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.